ProShare Advisors LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 129 filers reported holding GW PHARMACEUTICALS PLC in Q2 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$907,000
+69.5%
4,182
-9.8%
0.00%
+50.0%
Q4 2020$535,000
+13.8%
4,638
-3.9%
0.00%0.0%
Q3 2020$470,000
-19.5%
4,824
+1.4%
0.00%
-33.3%
Q2 2020$584,000
+64.0%
4,758
+17.1%
0.00%0.0%
Q1 2020$356,000
-46.5%
4,064
-36.2%
0.00%0.0%
Q4 2019$666,000
-27.3%
6,374
-20.0%
0.00%
-40.0%
Q3 2019$916,000
-37.8%
7,966
-6.7%
0.01%
-44.4%
Q2 2019$1,472,000
-11.4%
8,536
-13.4%
0.01%
-10.0%
Q1 2019$1,661,000
+87.7%
9,854
+8.4%
0.01%
+66.7%
Q4 2018$885,000
-52.8%
9,090
-16.2%
0.01%
-53.8%
Q3 2018$1,874,000
+20.5%
10,847
-2.6%
0.01%
+30.0%
Q2 2018$1,555,000
+12.8%
11,142
-9.0%
0.01%
+11.1%
Q1 2018$1,379,000
-17.9%
12,239
-3.9%
0.01%
-25.0%
Q4 2017$1,680,000
+25.2%
12,730
-3.7%
0.01%0.0%
Q3 2017$1,342,000
+11.4%
13,225
+10.0%
0.01%0.0%
Q2 2017$1,205,000
-18.7%
12,022
-2.0%
0.01%
-25.0%
Q1 2017$1,483,000
+6.6%
12,263
-1.5%
0.02%
+6.7%
Q4 2016$1,391,000
+4.5%
12,451
+24.1%
0.02%
-21.1%
Q3 2016$1,331,000
+26.4%
10,030
-12.8%
0.02%
+35.7%
Q2 2016$1,053,000
+28.9%
11,496
+1.6%
0.01%
+27.3%
Q1 2016$817,000
-3.3%
11,320
-7.0%
0.01%
+10.0%
Q4 2015$845,000
-19.1%
12,175
+6.4%
0.01%
-33.3%
Q3 2015$1,045,000
-10.7%
11,441
+20.1%
0.02%
-6.2%
Q2 2015$1,170,000
+35.3%
9,528
+0.3%
0.02%
+60.0%
Q1 2015$865,000
+62.3%
9,497
+20.5%
0.01%
+66.7%
Q4 2014$533,0007,8810.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2016
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 134,230$9,085,0005.95%
VHCP Management, LLC 311,853$21,106,0005.81%
Iguana Healthcare Management, LLC 60,000$4,061,0001.96%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 366,187$24,784,0000.95%
ACUTA CAPITAL PARTNERS, LLC 20,000$1,354,0000.92%
United Asset Strategies, Inc. 14,278$966,0000.41%
PRUDENTIAL PLC 823,408$55,728,0000.24%
Rock Springs Capital Management LP 28,000$1,895,0000.22%
CLOUGH CAPITAL PARTNERS L P 84,600$5,726,0000.20%
Eventide Asset Management 25,000$1,692,0000.18%
View complete list of GW PHARMACEUTICALS PLC shareholders